CorVel (CRVL) Competitors $108.84 +0.08 (+0.07%) As of 02:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DGX, LH, DVA, CHE, AMED, MD, AMN, CCRN, ERIE, and RYANShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Erie Indemnity (ERIE), and Ryan Specialty (RYAN). CorVel vs. Quest Diagnostics Laboratory Co. of America DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Erie Indemnity Ryan Specialty CorVel (NASDAQ:CRVL) and Quest Diagnostics (NYSE:DGX) are both business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation. Does the MarketBeat Community prefer CRVL or DGX? Quest Diagnostics received 348 more outperform votes than CorVel when rated by MarketBeat users. However, 63.84% of users gave CorVel an outperform vote while only 49.14% of users gave Quest Diagnostics an outperform vote. CompanyUnderperformOutperformCorVelOutperform Votes19663.84% Underperform Votes11136.16% Quest DiagnosticsOutperform Votes54449.14% Underperform Votes56350.86% Does the media favor CRVL or DGX? In the previous week, Quest Diagnostics had 22 more articles in the media than CorVel. MarketBeat recorded 33 mentions for Quest Diagnostics and 11 mentions for CorVel. CorVel's average media sentiment score of 1.72 beat Quest Diagnostics' score of 0.63 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Quest Diagnostics 15 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts recommend CRVL or DGX? Quest Diagnostics has a consensus price target of $185.07, indicating a potential upside of 4.42%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Quest Diagnostics is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69 Which has more volatility and risk, CRVL or DGX? CorVel has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Do insiders & institutionals believe in CRVL or DGX? 51.4% of CorVel shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 47.6% of CorVel shares are owned by company insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is CRVL or DGX more profitable? CorVel has a net margin of 10.12% compared to Quest Diagnostics' net margin of 8.80%. CorVel's return on equity of 32.22% beat Quest Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.12% 32.22% 17.66% Quest Diagnostics 8.80%15.07%6.72% Which has higher valuation & earnings, CRVL or DGX? Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$871.31M6.38$76.25M$1.7063.64Quest Diagnostics$10.16B1.95$871M$7.9122.41 SummaryQuest Diagnostics beats CorVel on 10 of the 19 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ ExchangeMarket Cap$5.58B$18.58B$7.30B$7.82BDividend YieldN/A1.43%2.58%4.22%P/E Ratio63.9623.7130.7118.48Price / Sales6.385.88172.23103.60Price / Cash57.1926.5531.5134.62Price / Book18.4617.705.034.25Net Income$76.25M$731.04M$195.49M$248.23M7 Day Performance-2.68%-0.61%0.76%0.89%1 Month Performance-4.60%-8.43%3.57%3.53%1 Year Performance34.88%6.50%12.65%5.09% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel0.9477 of 5 stars$108.84+0.1%N/A+36.6%$5.59B$871.31M64.024,230News CoveragePositive NewsDGXQuest Diagnostics4.569 of 5 stars$161.77-1.2%$181.33+12.1%+29.1%$18.06B$9.87B21.0449,000Analyst ForecastShort Interest ↑LHLaboratory Co. of America4.7186 of 5 stars$212.43-2.2%$268.77+26.5%+19.6%$17.77B$13.01B24.0975,500Earnings ReportAnalyst ForecastShort Interest ↑DVADaVita4.2789 of 5 stars$133.73-4.5%$166.33+24.4%+1.9%$10.70B$12.82B12.4570,000Positive NewsCHEChemed4.5727 of 5 stars$563.30-3.2%$667.00+18.4%+2.0%$8.23B$2.43B28.4614,200Analyst ForecastPositive NewsAMEDAmedisys2.9024 of 5 stars$91.83+0.1%$100.75+9.7%+3.1%$3.01B$2.35B36.4420,000Analyst RevisionMDPediatrix Medical Group2.0428 of 5 stars$12.04-6.1%$16.75+39.1%+45.7%$1.03B$2.01B-10.037,850Upcoming EarningsAMNAMN Healthcare Services4.2509 of 5 stars$17.84-3.5%$38.67+116.7%-65.9%$681.29M$2.98B-4.634,230Upcoming EarningsAnalyst RevisionNews CoverageCCRNCross Country Healthcare3.5268 of 5 stars$14.13-0.9%$18.41+30.3%-23.0%$463.65M$1.34B-282.542,700Analyst ForecastNews CoveragePositive NewsERIEErie Indemnity1.8041 of 5 stars$395.17-3.8%N/A-6.3%$18.25B$3.86B36.976,040Earnings ReportDividend AnnouncementAnalyst DowngradeRYANRyan Specialty3.6253 of 5 stars$67.57-4.3%$75.67+12.0%+32.6%$17.70B$2.52B97.933,850Positive News Related Companies and Tools Related Companies DGX Alternatives LH Alternatives DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives ERIE Alternatives RYAN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRVL Stock Free CRVL Stock Alerts